PSTI - Pluristem Therapeutics Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5153.52M
Enterprise Value 3131.69M
Trailing P/E N/A
Forward P/E 1-4.58
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)5.73
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-4.92

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2017
Most Recent Quarter (mrq)Sep 30, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-50.76%
Return on Equity (ttm)-100.84%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -26.76M
Net Income Avi to Common (ttm)-28.88M
Diluted EPS (ttm)-0.31
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)20.75M
Total Cash Per Share (mrq)0.19
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.79
Book Value Per Share (mrq)0.25

Cash Flow Statement

Operating Cash Flow (ttm)-22.88M
Levered Free Cash Flow (ttm)-12.77M

Trading Information

Stock Price History

Beta 0.35
52-Week Change 3-4.48%
S&P500 52-Week Change 317.93%
52 Week High 32.12
52 Week Low 31.04
50-Day Moving Average 31.53
200-Day Moving Average 31.40

Share Statistics

Avg Vol (3 month) 3655.45k
Avg Vol (10 day) 3214.43k
Shares Outstanding 5108.11M
Float 101.21M
% Held by Insiders 15.65%
% Held by Institutions 14.32%
Shares Short 31.65M
Short Ratio 32.11
Short % of Float 31.89%
Shares Short (prior month) 31.9M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/200
Last Split Date 3Nov 26, 2007